EGFR-T790M Mutation–Derived Interactome Rerouted EGFR Translocation Contributing to Gefitinib Resistance in Non-Small Cell Lung Cancer
Author:
Funder
Ministry of Science and Technology
Publisher
Elsevier BV
Subject
Molecular Biology,Biochemistry,Analytical Chemistry
Reference78 articles.
1. Lung cancer—a global perspective;McIntyre;J. Surg. Oncol.,2017
2. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022
3. Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): the road to a success, paved with failures;Lee;Pharmacol. Ther.,2017
4. The biology and management of non-small cell lung cancer;Herbst;Nature,2018
5. Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer;Wu;Mol. Cancer,2018
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors?;Cancers;2024-08-28
2. Tyrosine kinase inhibitors in the treatment of leptomeningeal carcinomatosis;Cell Biology International;2024-08-13
3. β-Elemene Reverses Gefitinib Resistance in NSCLC Cells by Inhibiting lncRNA H19-Mediated Autophagy;Pharmaceuticals;2024-05-14
4. Transformation of adenocarcinoma into small cell lung cancer as one of the mechanisms of acquired resistance to anti-EGFR tyrosine kinase inhibitors;Pathologia;2024-04-22
5. Facile construction of gefitinib‐loaded zeolitic imidazolate framework nanocomposites for the treatment of different lung cancer cells;Biotechnology and Applied Biochemistry;2024-04-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3